Off-site facilities: Friend or foe of outpatient parenteral antimicrobial therapy (OPAT)?
Infection Control & Hospital Epidemiology · 2024
DOI: 10.1017/ice.2024.20 ↗Kurz gefasst
Leserbrief in der Zeitschrift Infection Control & Hospital Epidemiology, 2024. Verfasst von Kelsey L Jensen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Mayo Clinic Health System, Austin, Minnesota. Hauptthemen laut MEDLINE: Ambulatory Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Mayo Clinic Health System, Austin, Minnesota.
- Department of Pharmacy, Mayo Clinic, Rochester, Minnesota.
- Department of Pharmacy, Mayo Clinic Health System, Cannon Falls, Minnesota.
ORCID-Profile: Kelsey L Jensen, Amy Van Abel, Paul Frykman, Christina G Rivera
Zitieren
APA
Jensen, K. L., Van Abel, A., Frykman, P., & Rivera, C. G. (2024). Off-site facilities: Friend or foe of outpatient parenteral antimicrobial therapy (OPAT)?. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2024.20
Vancouver
Jensen KL, Van Abel A, Frykman P, Rivera CG. Off-site facilities: Friend or foe of outpatient parenteral antimicrobial therapy (OPAT)?. Infection Control & Hospital Epidemiology. 2024. doi:10.1017/ice.2024.20
BibTeX
@article{Jensen2024,
author = {Jensen, Kelsey L and Van Abel, Amy and Frykman, Paul and Rivera, Christina G},
title = {Off-site facilities: Friend or foe of outpatient parenteral antimicrobial therapy (OPAT)?},
journal = {Infection Control & Hospital Epidemiology},
year = {2024},
doi = {10.1017/ice.2024.20}
}
EUVIMED